Close Menu
    Facebook X (Twitter) Instagram
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    Facebook X (Twitter) Instagram
    FlickonclickFlickonclick
    • Home
    • Entertainment
      • Biography Corner
      • Photos
    • Lifestyle
    • News
      • Finance
      • Fitness
      • Technology
    • Trending
    • Cricket
    • Advertise with Us
    FlickonclickFlickonclick
    Home » Finance » Tatva Chintan Pharma IPO: Should You Be Subscribing Or Not?
    Finance

    Tatva Chintan Pharma IPO: Should You Be Subscribing Or Not?

    By Parth ShuklaJuly 17, 2021
    Facebook Twitter WhatsApp Email Reddit

    There’s too much going on in the investment market of India and starting from Zomato opening its IPO, more are following such as Tatva Chintan Pharma, which is quite a reputated brand in its domain.




    They deal majorly in pharma products in verticals such as automotive, petroleum, pharmaceutical, agrochemicals, paints and coatings, dyes and pigments, personal care, and flavor and fragrances industries.

    Tatva Chintan Pharma IPO: Should You Be Subscribing Or Not?

    When did Tatva Chinta Pharma IPO started?

    The IPO had open for subscription from 16th July 2021 with ₹225 crores of fresh equity shares by the Tatva Chintan Pharma and ₹275 crores of an offer for sale (OFS) to its allied members.




    Do not forget that the Price brand for the company is ₹1,073 – ₹1,083 and it would turn out to be a good investment if it’s for the long term.

    There are other aspects in support of this being a good investment such as the analysis by some of the top tier stockbroking firms such as Investmentz. Here’s what they have to say.

    “The company earns 30% of revenue from pharmaceutical and agrochemical intermediates and other specialty chemicals, which are export orders shifted from China to India. With its superior product mix, established brand name, forward integration, strong relationships with multinationals, and adding capacities, we believe Tatva Chintan is likely to deliver healthy financial performance,” said a report by stockbroking platform Investmentz.



    Report analysis of Tatva China Pharma IPO

    It is clear from the report and what analysts says that if you’re into long-term investing then it would be a good option otherwise not.

    It is to be kept in mind that the Pharma industry is on an exponential growth pattern with 5-6% of growth observance in the upcoming five years. The industry is currently valued at a total of $800 billion (as measured back in 2019).

    Tatva Chintan Pharma has a strong record with a powerful balance sheet, and factors such as them being the key industry player and having high growth potential help their IPO uprising.

    Also Read- Zomato Announced IPO: Should You Be Subscribing It?




    IPO
    Previous ArticleAndroid Smartphones War: One Plus 09 Pro V/S Samsung Galaxy S21 Plus 5G
    Next Article Mastercard Ban: What’s The Reason Behind It And What Happens Next?

    Related Posts

    How to File ITR: Step-by-Step Process and Required Documents Explained

    June 22, 2025 Finance

    Big Update on Unified Pension Scheme: Government Adds These OPS Benefits – How Will You Benefit?

    June 19, 2025 Finance

    When and How Much Money You Can Withdraw from PF – Know EPFO’s New Rules

    June 18, 2025 Finance

    Why should you prioritise compliance when selecting a payment gateway for a website?

    June 17, 2025 Finance

    12% GST Tax Slab May Be Removed – From Food Items to Air Travel, Know What Will Get Cheaper and What Will Become Costlier

    June 12, 2025 Finance

    Best Stocks to Buy This Month: Updated June 2025

    May 29, 2025 Finance
    About Flickonclick

    Flickonclick brings you the latest updates across entertainment, lifestyle, tech, and more. Stay informed with trending news and stories that matter.

    Facebook X (Twitter) Instagram
    Recently Updated

    Top 15 Malayalam Hot & Sexy Movies to Watch Online in 2025

    By Virat VermaUpdated:June 23, 2025June 23, 2025

    Covid-19: Slowing Spread Doesn’t Mean the Threat Is Over — WHO Flags 6 Variants as Concerning

    June 23, 2025

    Sitaare Zameen Par Box Office Collection Day 3- Aamir Starrer Sees Huge Jump

    June 23, 2025

    Honda Launches New Honda City Sport Variant – Full Details on Price and Features

    June 23, 2025
    Important Links
    • Privacy Policy
    • Advertise with Us
    • Disclaimer
    • About Us
    • Contact Us
    • Write for Us
    • Home
    © 2025 Flickonclick

    Type above and press Enter to search. Press Esc to cancel.